8th September 2022, Nairobi The KUTRRH-KU Joint...
The second of its kind in Africa after Egypt. KUTRRH Cyberknife is set to revolutionize cancer treatment not only in Kenya but also in the region.
KUTRRH achieved another significant milestone with the launch of the formulary list by the KUTRRH CEO, Mr. Ahmed Dagane, on 3rd Aug 2022.
KUTRRH’s Dr. George Njoroge discovered Hepatitis C Treatment known as VictrelisTM on May 13, 2011, and was approved by the FDA.





